Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Background Prostate cancer recurrence is found in up to 40% of men with prior definitive (total prostatectomy or whole-prostate radiation) treatment. Prostate-specific membrane antigen PET agents such as 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid...

詳細記述

保存先:

書誌詳細
主要な著者:	Liza Lindenberg, Esther Mena, Barış Türkbey, Joanna H. Shih, Sarah E. Reese, Stephanie A. Harmon, Ilhan Lim, Frank I. Lin, Anita Ton, Yolanda McKinney, Philip Eclarinal, Deborah E. Citrin, William L. Dahut, Ravi A. Madan, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Peter A. Pinto, Janet F. Eary, Peter L. Choyke
フォーマット:	Artigo
言語:	英語
出版事項:	2020
オンライン･アクセス:	https://doi.org/10.1148/radiol.2020192018
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

このレコードへの初めてのコメントを付けませんか!

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRI

類似資料